Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases

Generation of Longitudinal Panomics Data to improve the Disease understanding of Anca-Associated Vasculitis

Charité – Universitätsmedizin Berlin will collect Biosamples from Anca-Associated Vasculitis Patients

Evotec will Leverage its Unique…

3 Min
More

Novozymes and Chr. Hansen announce name of future combined company; Novonesis

Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name reflects a new era of biosolutions where innovation in…

9 Min
More

Special topic | Cardiovascular health in Berlin-Brandenburg

Whether heart attack, stroke or other heart problems: Cardiovascular diseases are the most common cause of death in Germany. Even though mortality has fallen in recent years thanks to new examination and treatment methods, there is still a lot to be…

16 Min
More

Infection with stomach bacteria may increase risk of Alzheimer's disease - Researchers from Charité and McGill University quantify association between Helicobacter pylori and Alzheimer’s disease

Infection with the stomach bacterium Helicobacter pylori could increase the risk of developing Alzheimer’s disease: In people over the age of 50, the risk following a symptomatic infection can be an average of 11 percent higher, and even more about…

3 Min
More

Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform

Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform

3 Min
More

BIOTRONIK Opens New Asia-Pacific Hub in Singapore

New Asia-Pacific Hub Strengthens Singaporean MedTech Ecosystem

1 Min
More

TME PHARMA ANNOUNCES THE INITIATION OF THE LISTING OF PREFERENTIAL SUBSCRIPTION RIGHTS FOR FULLY GUARANTEED €2.7 MILLION CAPITAL INCREASE

- Guaranteed portion of the transaction will extend cash runway past

regulatory milestones in Q1-2024

- The financial visibility will allow TME Pharma to file and receive

feedback from FDA on its IND and applications to expedited regulatory …

1 Min
More

Establishment of the National Center for Tumor Diseases (NCT) Berlin

From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely…

5 Min
More

Bayer invests 130 million EUR in new production facility for innovative parenteral products

Investment part of billion-dollar investment program / Commitment to Berlin as an innovation hub / Governing Mayor of Berlin, Kai Wegner, inaugurates new facility together with Bayer Board Member Stefan Oelrich / New facility equipped with…

4 Min
More

Personalized cancer medicine: humans make better treatment decisions than AI - Charité study highlights limits of large language models in precision medicine

Treating cancer is becoming increasingly complex, but also offers more and more possibilities. After all, the better a tumor’s biology and genetic features are understood, the more treatment approaches there are. To be able to offer patients…

4 Min
More
Show more items